Skip to NavigationSkip to content

News

A new study has revealed that a promising stem cell therapy failed to improve ability to walk in patients with peripheral artery disease, a...
A device that delivers electronic pulses to the area around the ear, designed to stimulate the brain in order to mask symptoms of opioid withdrawal,...
The EMA has awarded European marketing authorisation to GlaxoSmithKline and Innovia’s single inhaler triple therapy Trelegy Ellipta for the...
NICE has announced that it has given the nod to two new treatments for breast cancer with the approval of Pfizer’s Ibrance and Novartis’ Kisqali.
Genentech first signed a deal with Arvinas, a biotech focused on drugs within the protein degradation class, back in 2015. Two years later and the...
It was World Diabetes Day yesterday and the NHS announced a new tech initiative to help those most at risk of developing type 2 diabetes. It was...
The CAR-T space has progressed rapidly over the last few years, culminating in FDA approvals for Novartis and Gilead to treat B-cell lymphomas;...
Researchers have discovered that people with psoriasis are more at risk of developing type 2 diabetes, with more severe forms of the condition...
Scott Gottlieb, the FDA’s Commissioner, issued an advisory about the medicinal plant-product known as kratom. The plant is known to act as a...
AstraZeneca and MedImmune have revealed the decision by the FDA to approve Fasenra (benralizumab) in the US as an add-on treatment for severe...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches